Clinical Trial Update: Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder

View source ↗

Summary

An update on the efficacy and safety of aripiprazole in patients with schizophrenia or bipolar disorder from a completed clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Schizophrenia, Bipolar Disorder | Status: COMPLETED